Drug Shortage Report for HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ

Last updated on 2022-02-09 History
Report ID 148893
Drug Identification Number 02209721
Brand name HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ
Common or Proper name Heparin Sodium in 5% Dextrose Injection 25,000 USP Units / 250 mL
Company Name B. BRAUN MEDICAL INC
Market Status MARKETED
Active Ingredient(s) DEXTROSE HEPARIN SODIUM
Strength(s) 5G 10000UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250 mL
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2021-12-15
Actual start date 2021-12-15
Estimated end date 2022-03-31
Actual end date 2022-02-08
Shortage status Resolved
Updated date 2022-02-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 824 TWELFTH AVENUE
BETHLEHEM, PENNSYLVANIA
UNITED STATES 18018
Company contact information Cindy Katsempris; cindy.katsempris@bbraunusa.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-02-09 English Compare
v13 2022-02-08 French Compare
v12 2022-02-08 English Compare
v11 2022-01-21 French Compare
v10 2022-01-21 English Compare
v9 2022-01-21 English Compare
v8 2021-12-16 English Compare
v7 2021-12-10 French Compare
v6 2021-12-10 English Compare
v5 2021-12-10 English Compare
v4 2021-11-10 French Compare
v3 2021-11-10 English Compare
v2 2021-11-05 French Compare
v1 2021-11-05 English Compare

Showing 1 to 14 of 14